1. Home
  2. ELV vs XNCR Comparison

ELV vs XNCR Comparison

Compare ELV & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elevance Health Inc.

ELV

Elevance Health Inc.

N/A

Current Price

$381.42

Market Cap

88.0B

Sector

Health Care

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$24.58

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELV
XNCR
Founded
1944
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.0B
2.0B
IPO Year
2001
2013

Fundamental Metrics

Financial Performance
Metric
ELV
XNCR
Price
$381.42
$24.58
Analyst Decision
Buy
Buy
Analyst Count
22
14
Target Price
★ $451.38
$31.42
AVG Volume (30 Days)
1.0M
★ 1.0M
Earning Date
10-20-2026
11-04-2026
Dividend Yield
★ 1.77%
N/A
EPS Growth
N/A
★ 65.36
EPS
★ 14.73
N/A
Revenue
★ $199,125,000,000.00
$125,576,000.00
Revenue This Year
N/A
$14.05
Revenue Next Year
$1.90
N/A
P/E Ratio
$26.54
★ N/A
Revenue Growth
12.49
★ 13.65
52 Week Low
$274.89
$10.38
52 Week High
$436.24
$30.61

Technical Indicators

Market Signals
Indicator
ELV
XNCR
Relative Strength Index (RSI) 37.53 51.52
Support Level $386.93 $23.36
Resistance Level $407.67 $30.61
Average True Range (ATR) 8.09 1.03
MACD -3.03 -0.09
Stochastic Oscillator 10.14 55.23

Price Performance

Historical Comparison
ELV
XNCR

About ELV Elevance Health Inc.

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: